+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Proteomics Market Research Report by Technology, by Reagent, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4858026
  • Report
  • June 2020
  • Region: Global
  • 230 pages
  • 360iResearch™
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Proteomics Market to Grow USD 40,700.62 Million by 2025, at a CAGR of 13.41%


  • Bruker Corporation
  • Creative Proteomics
  • Danaher Corporation
  • Danaher Corporation
  • GE Healthcare
  • Luminex Corporation
  • MORE
The Global Proteomics Market is expected to grow from USD 19,128.04 Million in 2019 to USD 40,700.62 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.41%.

Market Segmentation & Coverage:

This research report categorizes the Proteomics to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Technology, the Proteomics Market is examined across Chromatography, Electrophoresis, Protein Microarrays, Spectroscopy, and X-Ray Crystallography. The Chromatography further studied across Affinity Chromatography, HPLC, Ion Chromatography, and Supercritical Fluid Chromatography. The Electrophoresis further studied across Capillary Electrophoresis and Gel Electrophoresis. The Protein Microarrays further studied across Biochips and Microarray Instruments. The Spectroscopy further studied across CD Spectroscopy, Mass Spectroscopy, and NMR Spectroscopy.

On the basis of Offerings, the Proteomics Market is examined across Bioinformatics Software and Services and Core Proteomics Services. The Bioinformatics Software and Services further studied across Bioinformatics Databases, Bioinformatics Services, and Bioinformatics Tools. The Core Proteomics Services further studied across Custom Assay Services, Protein Characterization Services, Protein Identification Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, and Quantitative Proteomics Services.

On the basis of Reagent, the Proteomics Market is examined across Chromatography Reagents, Electrophoresis Reagents, Immunoassay Reagents, Protein Fractionation Reagents, Protein Microarray Reagents, Spectroscopy Reagents, and X-Ray Crystallography Reagents.

On the basis of Application, the Proteomics Market is examined across Clinical Diagnostics and Drug Discovery.

On the basis of Geography, the Proteomics Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Proteomics Market including Agilent Technologies, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, Perkinelmer, Inc., Promega Corporation, Thermo Fisher Scientific, Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Proteomics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Proteomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Proteomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Proteomics Market?
4. What is the competitive strategic window for opportunities in the Global Proteomics Market?
5. What are the technology trends and regulatory frameworks in the Global Proteomics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Proteomics Market?
Note: Product cover images may vary from those shown


  • Bruker Corporation
  • Creative Proteomics
  • Danaher Corporation
  • Danaher Corporation
  • GE Healthcare
  • Luminex Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window

3. Executive Summary
3.1. Market Outlook
3.2. Technology Outlook
3.3. Offerings Outlook
3.4. Reagent Outlook
3.5. Application Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Proteomics Market, By Geography

5. Market Dynamics
5.1. Introduction
5.1.1. Drivers Rising demand for personalized medicine Technology advancements Personalized proteomics for precision health Increasing R&D and government funding in pharmaceuticals and biotechnology
5.1.2. Restraints High cost associated with the instruments
5.1.3. Opportunities Growing prominence of nanoproteomics Integration of Omics data in biomedical sciences High growth potential in emerging countries
5.1.4. Challenges Data management in proteomics research Low ratio biomarkers discovery-to-approval ratio

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
6.3.1. Growing Focus on Monitoring Post-Translational Modifications
6.3.2. Increasing Uptake of Label-Free Quantification Techniques

7. Global Proteomics Market, By Technology
7.1. Introduction
7.2. Chromatography
7.2.1. Affinity Chromatography
7.2.2. HPLC
7.2.3. Ion Chromatography
7.2.4. Supercritical Fluid Chromatography
7.3. Electrophoresis
7.3.1. Capillary Electrophoresis
7.3.2. Gel Electrophoresis
7.4. Protein Microarrays
7.4.1. Biochips
7.4.2. Microarray Instruments
7.5. Spectroscopy
7.5.1. CD Spectroscopy
7.5.2. Mass Spectroscopy
7.5.3. NMR Spectroscopy
7.6. X-Ray Crystallography

8. Global Proteomics Market, By Offerings
8.1. Introduction
8.2. Bioinformatics Software and Services
8.2.1. Bioinformatics Databases
8.2.2. Bioinformatics Services
8.2.3. Bioinformatics Tools
8.3. Core Proteomics Services
8.3.1. Custom Assay Services
8.3.2. Protein Characterization Services
8.3.3. Protein Identification Services
8.3.4. Protein Purification Services
8.3.5. Protein Separation Services
8.3.6. Protein Sequencing Services
8.3.7. Quantitative Proteomics Services

9. Global Proteomics Market, By Reagent
9.1. Introduction
9.2. Chromatography Reagents
9.3. Electrophoresis Reagents
9.4. Immunoassay Reagents
9.5. Protein Fractionation Reagents
9.6. Protein Microarray Reagents
9.7. Spectroscopy Reagents
9.8. X-Ray Crystallography Reagents

10. Global Proteomics Market, By Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Drug Discovery

11. Americas Proteomics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Proteomics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand

13. Europe, Middle East & Africa Proteomics Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding

15. Company Usability Profiles
15.1. Agilent Technologies, Inc.
15.2. Agilent Technologies, Inc.
15.3. Bio-Rad Laboratories, Inc.
15.4. Bruker Corporation
15.5. Creative Proteomics
15.6. Danaher Corporation
15.7. Danaher Corporation
15.8. GE Healthcare
15.9. Luminex Corporation
15.10. Merck KGaA
15.11. Perkinelmer, Inc.
15.12. Promega Corporation
15.13. Thermo Fisher Scientific, Inc.
15.14. Thermo Fisher Scientific, Inc.
15.15. Waters Corporation

16. Appendix
16.1. Discussion Guide
16.2. Edition Details
16.3. License Details
16.4. Pricing Details
Note: Product cover images may vary from those shown
  • Agilent Technologies, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Creative Proteomics
  • Danaher Corporation
  • Danaher Corporation
  • GE Healthcare
  • Luminex Corporation
  • Merck KGaA
  • Perkinelmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
Note: Product cover images may vary from those shown